ArticlePloS one2026
Dimercaprol (BAL): Insights into conformational stability, fragmentation pathways via tandem LR-ESI, HR-EI mass spectrometry, and gas-phase thermochemical properties from quantum chemical calculations.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dimercaprol (British antilewisite, BAL) is a long-established chelating agent used in the treatment of heavy metal poisoning; however, its physicochemical and thermochemical properties have not yet been fully characterized. In this study, we combined gas-phase quantum chemical calculations with high-resolution mass spectrometry to investigate the conformational stability, fragmentation pathways, and thermochemical parameters of BAL. Fragmentation behavior was examined by gas chromatography/mass spectrometry-QTOF under electronic ionization conditions, and the resulting spectra were interpreted through proposed dissociation pathways involving water, hydrogen sulfide, and thiyl radical losses, supported by reaction enthalpies calculated at the theoretical level M06-2X/6-311++G(3df,3pd). Conformational analysis identified five low-energy structures (BAL-1 to BAL-5), where intramolecular hydrogen bonds and gauche/anti interactions play a key role in stability; BAL-3 was consistently predicted as the lowest-energy conformer. Vibrational frequencies calculated with the B3LYP, M06-2X, and MN15 functionals showed good agreement with experimental FTIR and Raman data. The thermochemical properties were further evaluated using Gn composite methods (G3MP2B3, G3B3, G4MP2 and G4) which yielded an average standard enthalpy of formation at ΔH°(f,298K) of -45.6 ± 1.1 kcal/mol. This work provides a detailed experimental and theoretical characterization of dimercaprol, providing information on its possible fragmentation mechanism and conformational landscape, and offering a thermochemical framework that could support future pharmacological, toxicological and environmental applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.